WHO ICTRP trial
TADAM, a Belgian project of Heroin-Assisted Treatment - TADAM
EUCTR2010-019026-13-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-019026-13-BE |
|---|---|
| Public title | TADAM, a Belgian project of Heroin-Assisted Treatment - TADAM |
| Scientific title | TADAM, a Belgian project of Heroin-Assisted Treatment - TADAM |
| Primary sponsor | University of Liège |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Belgium |
| Conditions | treatment resistant heroin addiction |
| Interventions | Trade Name: Diacetylmorfine, poeder voor inhalatiedamp (75 mg, 100 mg, 150 mg and 200 mg) Product Name: Diacetylmorphine Product Code: Diacetylmorphine Pharmaceutical Form: Inhalation powder INN or Proposed INN: Diacetylmorphine CAS Number… |
| Registration date | Mar 29, 2010 |
| Target size | 200 |
| Secondary IDs | TADAM_Ulg |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: